loading
전일 마감가:
$2.77
열려 있는:
$2.815
하루 거래량:
2,759
Relative Volume:
0.42
시가총액:
$4.32M
수익:
$2.54M
순이익/손실:
$-4.13M
주가수익비율:
-1.0509
EPS:
-2.75
순현금흐름:
$-4.11M
1주 성능:
+3.21%
1개월 성능:
+17.24%
6개월 성능:
-23.65%
1년 성능:
-32.32%
1일 변동 폭
Value
$2.78
$2.89
1주일 범위
Value
$2.6612
$2.9218
52주 변동 폭
Value
$2.20
$5.20

Xenetic Biosciences Inc Stock (XBIO) Company Profile

Name
명칭
Xenetic Biosciences Inc
Name
전화
781-778-7720
Name
주소
945 CONCORD ST., FRAMINGHAM, MA
Name
직원
2
Name
트위터
@XeneticBio
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
XBIO's Discussions on Twitter

XBIO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
XBIO
Xenetic Biosciences Inc
2.89 4.32M 2.54M -4.13M -4.11M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.19 127.64B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
603.58 65.95B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
656.65 37.92B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
273.55 32.98B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
254.16 26.92B 3.81B -644.79M -669.77M -6.24

Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-01-08 개시 Maxim Group Buy

Xenetic Biosciences Inc 주식(XBIO)의 최신 뉴스

pulisher
May 05, 2025

Xenetic Biosciences Inc expected to post a loss of 72 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 04, 2025

Xenetic Biosciences, Inc. Announces Executive Leadership Transition - ACCESS Newswire

May 04, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 01, 2025

Xenetic Biosciences (XBIO) to Release Earnings on Thursday - Defense World

May 01, 2025
pulisher
Apr 27, 2025

Xenetic Biosciences, Inc. Reports 2018 Year End Results and Provides Corporate Update - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Xenetic Biosciences, Inc. Receives Approval to Commence Exploratory Study of XCART(TM) - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 19, 2025

Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Update - Defense World

Apr 19, 2025
pulisher
Apr 11, 2025

Analyzing Ampio Pharmaceuticals (NYSE:AMPE) & Xenetic Biosciences (NASDAQ:XBIO) - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Xenetic Biosciences (NASDAQ:XBIO) Earns Neutral Rating from HC Wainwright - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Xenetic Biosciences appoints new accounting firm By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

Xenetic Biosciences appoints new accounting firm - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

Wainwright maintains Neutral on Xenetic shares after segment - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

Wainwright maintains Neutral on Xenetic shares after segment By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 09, 2025

Xenetic Biosciences, Inc. Releases Virtual Investor "What This M - GuruFocus

Apr 09, 2025
pulisher
Apr 09, 2025

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment - guardonline.com

Apr 09, 2025

Xenetic Biosciences Inc (XBIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
자본화:     |  볼륨(24시간):